Spencer B. King III, MD
Potential Financial Conflicts of Interest:Consultancies: BMS Sanofi, Kos Pharmaceuticals, Eli Lilly, Merck & Co., GlaxoSmithKline; Honoraria: BMS Sanofi, Kos Pharmaceuticals, Eli Lilly, Merck & Co.; Grants received: Guidant, Johnson & Johnson, Medtronic, Boston Scientific, Merck & Co.; Royalties: Novoste, Inc. Dr. King has been on the data safety and monitoring boards of trials sponsored by Guidant, Johnson & Johnson, Medtronic, Boston Scientific, and The Medicines Co.
Requests for Single Reprints: Spencer B. King III, MD, Fuqua Heart Center, 95 Collier Road, Atlanta, GA 30309.
Spencer B. King III. Why Have Stents Replaced Balloons? Underwhelming Evidence. Ann Intern Med. 2003;138:842–843. doi: 10.7326/0003-4819-138-10-200305200-00013
Download citation file:
Published: Ann Intern Med. 2003;138(10):842-843.
Acute Coronary Syndromes, Cardiology, Coronary Heart Disease, Emergency Medicine, Percutaneous Coronary Intervention.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use